Clinical trial
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell…
NCT00113646 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00113646 |
|---|---|
| Title | Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies |
| Official title | Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Leukemia, Multiple Myeloma, Myelodysplastic Syndrome |
| Intervention type | Drug, Procedure |
| Interventions | MEDI-507, Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant |
| Enrollment | 14 |
| Start date | Nov 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 10, 2005 |
| Last update posted | Mar 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: